PAXMEDICA

PaxMedica is a clinical-stage biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders. Our lead programs are focused on two of the world's most challenging conditions - Autism Spectrum Disorder (ASD) and Fragile X-associated Tremor / Ataxia (FXTAS). There are no FDA-approved treatments for the core symptoms of ASD and no FDA-approved treatments at all for FXTAS. We are on a promising path to change that... PaxMedica's lead product in development may help eliminate, reduce, or modulate some of the more troublesome aspects of these processes. That opens the potential for people with autism to integrate their behavior with others more successfully and improve their lives. And that would be a significant advance for them and everyone they touch - families, friends, and the larger world around them.

Also known as: PaxMedica, Inc.

Primary location: Tarrytown United States